Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ)’s share price was up 3.4% on Thursday . The company traded as high as $28.67 and last traded at $28.58, with a volume of 250,188 shares. The stock had previously closed at $27.65.

A number of equities analysts have recently weighed in on ZLTQ shares. TheStreet upgraded Zeltiq Aesthetics from a “hold” rating to a “buy” rating in a research note on Wednesday, April 20th. Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, June 30th. Brean Capital restated a “buy” rating and issued a $35.00 target price on shares of Zeltiq Aesthetics in a research note on Tuesday, June 21st. Stifel Nicolaus restated a “buy” rating and issued a $38.00 target price on shares of Zeltiq Aesthetics in a research note on Friday, May 13th. Finally, Piper Jaffray Cos. restated an “overweight” rating and issued a $40.00 target price on shares of Zeltiq Aesthetics in a research note on Monday, May 2nd. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Zeltiq Aesthetics currently has a consensus rating of “Buy” and an average price target of $36.25.

The stock’s 50 day moving average price is $27.82 and its 200 day moving average price is $26.15. The firm has a market cap of $1.16 billion and a price-to-earnings ratio of 35.31.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last announced its quarterly earnings data on Tuesday, May 10th. The company reported ($0.25) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.25). During the same quarter in the previous year, the business earned ($0.06) earnings per share. The firm had revenue of $64.50 million for the quarter, compared to the consensus estimate of $61.80 million. The firm’s revenue for the quarter was up 25.0% on a year-over-year basis. Equities analysts forecast that Zeltiq Aesthetics Inc. will post $0.01 earnings per share for the current fiscal year.

In other news, Director Mary Fisher sold 1,863 shares of the firm’s stock in a transaction on Wednesday, April 13th. The shares were sold at an average price of $30.00, for a total transaction of $55,890.00. Following the sale, the director now directly owns 3,923 shares in the company, valued at approximately $117,690. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Sergio Garcia sold 5,000 shares of the firm’s stock in a transaction on Wednesday, April 13th. The shares were sold at an average price of $30.00, for a total transaction of $150,000.00. Following the sale, the vice president now owns 70,725 shares in the company, valued at $2,121,750. The disclosure for this sale can be found here.

Other hedge funds have recently made changes to their positions in the company. Russell Frank Co increased its stake in shares of Zeltiq Aesthetics by 98.0% in the fourth quarter. Russell Frank Co now owns 211,197 shares of the company’s stock valued at $6,044,000 after buying an additional 104,550 shares during the last quarter. California State Teachers Retirement System increased its stake in shares of Zeltiq Aesthetics by 1.7% in the fourth quarter. California State Teachers Retirement System now owns 59,726 shares of the company’s stock valued at $1,704,000 after buying an additional 984 shares during the last quarter. New York State Common Retirement Fund increased its stake in shares of Zeltiq Aesthetics by 4.3% in the fourth quarter. New York State Common Retirement Fund now owns 41,532 shares of the company’s stock valued at $1,185,000 after buying an additional 1,700 shares during the last quarter. EAM Investors LLC increased its stake in shares of Zeltiq Aesthetics by 3.5% in the fourth quarter. EAM Investors LLC now owns 78,374 shares of the company’s stock valued at $2,236,000 after buying an additional 2,670 shares during the last quarter. Finally, CAM Group Holding A S increased its stake in shares of Zeltiq Aesthetics by 100.0% in the fourth quarter. CAM Group Holding A S now owns 150,000 shares of the company’s stock valued at $4,280,000 after buying an additional 75,000 shares during the last quarter.

ZELTIQ Aesthetics, Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.